Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Twenty years of experience on stem cell transplantation in iran.
[Acute disseminated encephalomyelitis is an important differential diagnosis in the acutely affected child].
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
[Demyelinating diseases in children with acute neurological symptoms].
The cerebellar channelopathy of multiple sclerosis.
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity.
[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia].
Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.
Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment.
Pseudobulbar affect: prevalence and management.
Autoimmunity in multiple sclerosis need not be abnormal.
Isolated dysphagia due to aquaporin-4 autoimmunity.
The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »